Association between the COVID-19 pandemic and pertussis derived from multiple nationwide data sources, France, 2013 to 2020.


Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
06 2022
Historique:
entrez: 24 6 2022
pubmed: 25 6 2022
medline: 28 6 2022
Statut: ppublish

Résumé

BackgroundInterventions to mitigate the COVID-19 pandemic may impact other respiratory diseases.AimsWe aimed to study the course of pertussis in France over an 8-year period including the beginning of the COVID-19 pandemic and its association with COVID-19 mitigation strategies, using multiple nationwide data sources and regression models.MethodsWe analysed the number of French pertussis cases between 2013 and 2020, using PCR test results from nationwide outpatient laboratories (Source 1) and a network of the paediatric wards from 41 hospitals (Source 2). We also used reports of a national primary care paediatric network (Source 3). We conducted a quasi-experimental interrupted time series analysis, relying on negative binomial regression models. The models accounted for seasonality, long-term cycles and secular trend, and included a binary variable for the first national lockdown (start 16 March 2020).ResultsWe identified 19,039 pertussis cases from these data sources. Pertussis cases decreased significantly following the implementation of mitigation measures, with adjusted incidence rate ratios of 0.10 (95% CI: 0.04-0.26) and 0.22 (95% CI: 0.07-0.66) for Source 1 and Source 2, respectively. The association was confirmed in Source 3 with a median of, respectively, one (IQR: 0-2) and 0 cases (IQR: 0-0) per month before and after lockdown (p = 0.0048).ConclusionsThe strong reduction in outpatient and hospitalised pertussis cases suggests an impact of COVID-19 mitigation measures on pertussis epidemiology. Pertussis vaccination recommendations should be followed carefully, and disease monitoring should be continued to detect any resurgence after relaxation of mitigation measures.

Identifiants

pubmed: 35748301
doi: 10.2807/1560-7917.ES.2022.27.25.2100933
pmc: PMC9229195
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Lancet Infect Dis. 2017 Sep;17(9):974-980
pubmed: 28623146
J Med Virol. 2021 Jan;93(1):153-154
pubmed: 32617991
Lancet Infect Dis. 2022 Feb;22(2):265-273
pubmed: 34672963
Proc Biol Sci. 2016 Jan 13;283(1822):
pubmed: 26763701
Vaccine. 2021 Jan 15;39(3):505-511
pubmed: 33357956
Euro Surveill. 2020 Nov;25(47):
pubmed: 33243355
Vaccine. 2017 Oct 27;35(45):6083-6088
pubmed: 28974408
Int J Environ Res Public Health. 2021 Jun 03;18(11):
pubmed: 34205018
Pediatr Infect Dis J. 2015 Aug;34(8):814-20
pubmed: 25955837
Pediatr Infect Dis J. 2021 Dec 1;40(12):e511-e514
pubmed: 34260480
JAMA. 2021 Jun 8;325(22):2247-2248
pubmed: 34028492
Clin Infect Dis. 2021 Nov 2;73(9):e2829-e2830
pubmed: 33594407
Front Pediatr. 2021 May 28;9:666848
pubmed: 34123969
Infect Dis Now. 2021 Aug;51(5):418-423
pubmed: 33991720
BMJ. 2015 Jun 09;350:h2750
pubmed: 26058820
J Med Virol. 2021 Mar;93(3):1814-1816
pubmed: 33079384
J Clin Microbiol. 2016 Aug;54(8):2169-71
pubmed: 27194689
Eur J Clin Microbiol Infect Dis. 2021 Nov;40(11):2389-2395
pubmed: 34347190
Lancet Infect Dis. 2018 Jan;18(1):5-6
pubmed: 29066129
N Engl J Med. 2012 Aug 30;367(9):785-7
pubmed: 22894554
Clin Infect Dis. 2021 Jan 27;72(2):319-322
pubmed: 33501967
Pediatr Pulmonol. 2021 Dec;56(12):3669-3673
pubmed: 34473914
Clin Infect Dis. 2021 Apr 8;72(7):e184-e191
pubmed: 33150393
Commun Dis Intell (2018). 2021 Feb 26;45:
pubmed: 33632091
Arch Dis Child. 2022 Mar;107(3):e19
pubmed: 34857511

Auteurs

Soraya Matczak (S)

Institut Pasteur, Université Paris Cité, Biodiversity and Epidemiology of Bacterial Pathogens, Paris, France.
Department of General Pediatrics and Pediatric Infectious Diseases, Hôpital Necker-Enfants Malades, APHP, Université Paris Cité, Paris, France.

Corinne Levy (C)

Université Paris Est, IMRB-GRC GEMINI, Créteil, France.
ACTIV, Association Clinique et Thérapeutique Infantile du Val-de-Marne, Créteil, France.
GPIP, Groupe de Pathologie Infectieuse Pédiatrique, Paris, France.
Clinical Research Center (CRC), Centre Hospitalier Intercommunal de Créteil, Créteil, France.
AFPA, Association Française de Pédiatrie Ambulatoire, Saint-Germain-en-Laye, France.

Camille Fortas (C)

Santé publique France, French National Public Health Agency, Saint-Maurice, France.

Jérémie F Cohen (JF)

Department of General Pediatrics and Pediatric Infectious Diseases, Hôpital Necker-Enfants Malades, APHP, Université Paris Cité, Paris, France.
Obstetrical, Perinatal and Pediatric Epidemiology Research Team, Center of Research in Epidemiology and Statistics, INSERM UMR 1153, Université Paris Cité, Paris, France.

Stéphane Béchet (S)

Clinical Research Center (CRC), Centre Hospitalier Intercommunal de Créteil, Créteil, France.

Fatima Aït El Belghiti (F)

Santé publique France, French National Public Health Agency, Saint-Maurice, France.

Sophie Guillot (S)

National Reference Center for Whooping Cough and other Bordetella infections, Institut Pasteur, Paris, France.

Sabine Trombert-Paolantoni (S)

Laboratoire CERBA, Saint Ouen l'Aumône, France.

Véronique Jacomo (V)

Laboratoire Eurofins Biomnis, Lyon, France.

Yann Savitch (Y)

Santé publique France, French National Public Health Agency, Saint-Maurice, France.

Juliette Paireau (J)

Institut Pasteur, Université Paris Cité, CNRS UMR2000, Mathematical Modelling of Infectious Diseases Unit, Paris, France.
Santé publique France, French National Public Health Agency, Saint-Maurice, France.

Sylvain Brisse (S)

Institut Pasteur, Université Paris Cité, Biodiversity and Epidemiology of Bacterial Pathogens, Paris, France.
National Reference Center for Whooping Cough and other Bordetella infections, Institut Pasteur, Paris, France.

Nicole Guiso (N)

Institut Pasteur, Paris, France.

Daniel Lévy-Bruhl (D)

Santé publique France, French National Public Health Agency, Saint-Maurice, France.

Robert Cohen (R)

Université Paris Est, IMRB-GRC GEMINI, Créteil, France.
ACTIV, Association Clinique et Thérapeutique Infantile du Val-de-Marne, Créteil, France.
GPIP, Groupe de Pathologie Infectieuse Pédiatrique, Paris, France.
Clinical Research Center (CRC), Centre Hospitalier Intercommunal de Créteil, Créteil, France.
AFPA, Association Française de Pédiatrie Ambulatoire, Saint-Germain-en-Laye, France.

Julie Toubiana (J)

Institut Pasteur, Université Paris Cité, Biodiversity and Epidemiology of Bacterial Pathogens, Paris, France.
National Reference Center for Whooping Cough and other Bordetella infections, Institut Pasteur, Paris, France.
Department of General Pediatrics and Pediatric Infectious Diseases, Hôpital Necker-Enfants Malades, APHP, Université Paris Cité, Paris, France.
GPIP, Groupe de Pathologie Infectieuse Pédiatrique, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH